Chemotherapy Ineffective To Treat Patients With Pancreatic Cancer
Chemotherapy drugs works primarily on cancer cells that are dividing or proliferating, when cancer cells suspend their proliferation, the drugs do not target them well.
Chemotherapy drugs works primarily on cancer cells that are dividing or proliferating, when cancer cells suspend their proliferation, the drugs do not target them well.
‘Access to circulating tumor cells may help doctors define the diagnosis and guide treatment for pancreatic cancer.’
Tweet it Now
Because these cells are often larger, irregularly shaped and tend to cluster together, they get trapped in smaller vessels. The authors hypothesized that most cells released from a gastrointestinal tumor would flow into the portal vein and then get trapped by the narrow vessels in the liver. Hence, they would not reach the peripheral venous system. CTCs from gastrointestinal tumors are rarely identified in the peripheral blood until the cancer is widely metastatic. To test this theory, the researchers used an ultrasound-guided endoscope and a small needle to take blood from the portal vein during routine diagnostic endoscopies.
They found CTCs in 100 percent of 18 patients with suspected tumors in the pancreas and bile ducts. Tests using peripheral blood samples, the standard method, detected tumors cells in only four of the 18 patients.
St George�s Hall Turns Purple in Support of Pancreatic Cancer
St Georges Hall was lit up purple for Pancreatic Cancer Awareness Month, organized by the family of 67-year-old West Derby mum Lydia Gallagher.
St Georges Hall was lit up purple for Pancreatic Cancer Awareness Month, organized by the family of 67-year-old West Derby mum Lydia Gallagher.
Source-IANS
Onivyde With Fluorouracil and Leucovorin Approved to Treat Advanced Pancreatic Cancer
The U.S. Food and Drug Administration has approved Onivyde in combination with fluorouracil and leucovorin to treat patients with advanced pancreatic cancer.
The U.S. Food and Drug Administration has approved Onivyde in combination with fluorouracil and leucovorin to treat patients with advanced pancreatic cancer.
New Drug Combo Could Combat Pancreatic Cancer Better Than The Existing Drug
The combination of an experimental drug with an existing one reduced the viability of cancer cells by about 50 percent when compared with everolimus alone.
The combination of an experimental drug with an existing one reduced the viability of cancer cells by about 50 percent when compared with everolimus alone.
